WELLS FARGO & COMPANY/MN - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 26 filers reported holding CASI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,0000.0%713
+0.4%
0.00%
Q4 2021$1,0000.0%7100.0%0.00%
Q3 2021$1,0000.0%710
+15.1%
0.00%
Q2 2021$1,000
-99.8%
617
-99.6%
0.00%
Q1 2021$411,000
-18.0%
171,157
+0.8%
0.00%
Q4 2020$501,000
+101.2%
169,768
+4.2%
0.00%
Q3 2020$249,000
-30.3%
162,864
+14.2%
0.00%
Q2 2020$357,000
+288.0%
142,561
+214.6%
0.00%
Q1 2020$92,000
-28.7%
45,308
+8.1%
0.00%
Q4 2019$129,000
-50.6%
41,896
-46.4%
0.00%
Q3 2019$261,000
+12.5%
78,114
+7.5%
0.00%
Q2 2019$232,000
+26.8%
72,643
+13.7%
0.00%
Q1 2019$183,000
-28.5%
63,878
+0.3%
0.00%
Q4 2018$256,000
-12.3%
63,680
+1.7%
0.00%
Q3 2018$292,000
-13.6%
62,606
+52.2%
0.00%
Q2 2018$338,00041,138
+68463.3%
0.00%
Q1 2018$060
+20.0%
0.00%
Q4 2017$050
-26.5%
0.00%
Q3 2017$0680.0%0.00%
Q2 2017$0680.0%0.00%
Q1 2017$068
-30.6%
0.00%
Q4 2016$098
+22.5%
0.00%
Q3 2016$0800.0%0.00%
Q2 2016$0800.0%0.00%
Q1 2016$080
+29.0%
0.00%
Q4 2015$0620.0%0.00%
Q3 2015$0620.0%0.00%
Q2 2015$062
-50.0%
0.00%
Q1 2015$0124
+100.0%
0.00%
Q4 2014$0620.0%0.00%
Q3 2014$0620.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders